Skip to Content

Mipomersen use while Breastfeeding

Drugs containing Mipomersen: Kynamro

Medically reviewed by Drugs.com. Last updated on March 28, 2021.

Mipomersen Levels and Effects while Breastfeeding

Summary of Use during Lactation

No relevant published information exists with the use of mipomersen during breastfeeding. Because of a concern with disruption of infant lipid metabolism, mipomersen should not be used during breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Cholestyramine, Colesevelam, Colestipol

Substance Identification

Substance Name

Mipomersen

CAS Registry Number

1000120-98-8

Drug Class

  • Breast Feeding
  • Lactation
  • Anticholesteremic Agents
  • Antilipemic Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.